FDA Import Refusal SCS-6340856-4/11/4 — Apex Laboratories Private Ltd
The FDA refused shipment SCS-6340856-4/11/4 from Apex Laboratories Private Ltd (India) on March 28, 2023. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- March 28, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VCA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75